FAK‐kinase inhibition induced RTK activation in RTK high cancer cells while the selective pressure of FAK‐kinase inhibition was able to drive RTK low triple‐negative breast cancer cells to express human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is cancer.